|
|
Article: The Medicines Company Added to Bellwether Watch List.
- Article from:
- M2 Presswire
- Article date:
- April 27, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-27 April 2007-Biotech News: The Medicines Company Added to Bellwether Watch List(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:27042007
The Medicines Company is like a football player who takes over at the five yard line and scores the winning touchdown. The drug company acquires and wins approval for drugs in late stages of development. Flagship drug Angiomax is an anticoagulant touted as an alternative to heparin which is used to treat balloon angioplasty patients in the US and Canada; the product is also sold in Europe as Angiox by partner Nycomed Danmark. The company is further investigating cardiovascular applications for the drug. Also in ...
Related newspaper, magazine, and journal articles:
|